nodes	percent_of_prediction	percent_of_DWPC	metapath
Varenicline—Body temperature increased—Fluorouracil—pancreatic cancer	0.000572	0.000572	CcSEcCtD
Varenicline—Palpitations—Docetaxel—pancreatic cancer	0.000565	0.000565	CcSEcCtD
Varenicline—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000565	0.000565	CcSEcCtD
Varenicline—Weight increased—Epirubicin—pancreatic cancer	0.000564	0.000564	CcSEcCtD
Varenicline—Loss of consciousness—Docetaxel—pancreatic cancer	0.000562	0.000562	CcSEcCtD
Varenicline—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000559	0.000559	CcSEcCtD
Varenicline—Cough—Docetaxel—pancreatic cancer	0.000558	0.000558	CcSEcCtD
Varenicline—Angina pectoris—Doxorubicin—pancreatic cancer	0.000558	0.000558	CcSEcCtD
Varenicline—Hypersensitivity—Irinotecan—pancreatic cancer	0.000557	0.000557	CcSEcCtD
Varenicline—Convulsion—Docetaxel—pancreatic cancer	0.000554	0.000554	CcSEcCtD
Varenicline—Hypertension—Docetaxel—pancreatic cancer	0.000552	0.000552	CcSEcCtD
Varenicline—Infestation—Epirubicin—pancreatic cancer	0.000552	0.000552	CcSEcCtD
Varenicline—Infestation NOS—Epirubicin—pancreatic cancer	0.000552	0.000552	CcSEcCtD
Varenicline—Bronchitis—Doxorubicin—pancreatic cancer	0.000551	0.000551	CcSEcCtD
Varenicline—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000548	0.000548	CcSEcCtD
Varenicline—Myalgia—Docetaxel—pancreatic cancer	0.000545	0.000545	CcSEcCtD
Varenicline—Chest pain—Docetaxel—pancreatic cancer	0.000545	0.000545	CcSEcCtD
Varenicline—Arthralgia—Docetaxel—pancreatic cancer	0.000545	0.000545	CcSEcCtD
Varenicline—Nausea—Sunitinib—pancreatic cancer	0.000545	0.000545	CcSEcCtD
Varenicline—Asthenia—Irinotecan—pancreatic cancer	0.000542	0.000542	CcSEcCtD
Varenicline—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000541	0.000541	CcSEcCtD
Varenicline—Stomatitis—Epirubicin—pancreatic cancer	0.000538	0.000538	CcSEcCtD
Varenicline—Conjunctivitis—Epirubicin—pancreatic cancer	0.000537	0.000537	CcSEcCtD
Varenicline—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000533	0.000533	CcSEcCtD
Varenicline—Dry mouth—Docetaxel—pancreatic cancer	0.000533	0.000533	CcSEcCtD
Varenicline—Pollakiuria—Doxorubicin—pancreatic cancer	0.000529	0.000529	CcSEcCtD
Varenicline—Asthenia—Gemcitabine—pancreatic cancer	0.000528	0.000528	CcSEcCtD
Varenicline—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000523	0.000523	CcSEcCtD
Varenicline—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000522	0.000522	CcSEcCtD
Varenicline—Oedema—Docetaxel—pancreatic cancer	0.000522	0.000522	CcSEcCtD
Varenicline—Weight increased—Doxorubicin—pancreatic cancer	0.000522	0.000522	CcSEcCtD
Varenicline—Epistaxis—Epirubicin—pancreatic cancer	0.000521	0.000521	CcSEcCtD
Varenicline—Pruritus—Gemcitabine—pancreatic cancer	0.000521	0.000521	CcSEcCtD
Varenicline—Infection—Docetaxel—pancreatic cancer	0.000519	0.000519	CcSEcCtD
Varenicline—Sinusitis—Epirubicin—pancreatic cancer	0.000518	0.000518	CcSEcCtD
Varenicline—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000517	0.000517	CcSEcCtD
Varenicline—Diarrhoea—Irinotecan—pancreatic cancer	0.000517	0.000517	CcSEcCtD
Varenicline—Shock—Docetaxel—pancreatic cancer	0.000514	0.000514	CcSEcCtD
Varenicline—Nervous system disorder—Docetaxel—pancreatic cancer	0.000512	0.000512	CcSEcCtD
Varenicline—Pruritus—Fluorouracil—pancreatic cancer	0.000512	0.000512	CcSEcCtD
Varenicline—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000511	0.000511	CcSEcCtD
Varenicline—Infestation NOS—Doxorubicin—pancreatic cancer	0.000511	0.000511	CcSEcCtD
Varenicline—Infestation—Doxorubicin—pancreatic cancer	0.000511	0.000511	CcSEcCtD
Varenicline—Tachycardia—Docetaxel—pancreatic cancer	0.00051	0.00051	CcSEcCtD
Varenicline—Skin disorder—Docetaxel—pancreatic cancer	0.000507	0.000507	CcSEcCtD
Varenicline—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000507	0.000507	CcSEcCtD
Varenicline—Bradycardia—Epirubicin—pancreatic cancer	0.000505	0.000505	CcSEcCtD
Varenicline—Diarrhoea—Gemcitabine—pancreatic cancer	0.000504	0.000504	CcSEcCtD
Varenicline—Dizziness—Irinotecan—pancreatic cancer	0.0005	0.0005	CcSEcCtD
Varenicline—Stomatitis—Doxorubicin—pancreatic cancer	0.000498	0.000498	CcSEcCtD
Varenicline—Anorexia—Docetaxel—pancreatic cancer	0.000498	0.000498	CcSEcCtD
Varenicline—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000497	0.000497	CcSEcCtD
Varenicline—Diarrhoea—Fluorouracil—pancreatic cancer	0.000495	0.000495	CcSEcCtD
Varenicline—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000493	0.000493	CcSEcCtD
Varenicline—Urinary tract disorder—Epirubicin—pancreatic cancer	0.00049	0.00049	CcSEcCtD
Varenicline—Oedema peripheral—Epirubicin—pancreatic cancer	0.000488	0.000488	CcSEcCtD
Varenicline—Hypotension—Docetaxel—pancreatic cancer	0.000488	0.000488	CcSEcCtD
Varenicline—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000487	0.000487	CcSEcCtD
Varenicline—Urethral disorder—Epirubicin—pancreatic cancer	0.000486	0.000486	CcSEcCtD
Varenicline—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000483	0.000483	CcSEcCtD
Varenicline—Epistaxis—Doxorubicin—pancreatic cancer	0.000482	0.000482	CcSEcCtD
Varenicline—Vomiting—Irinotecan—pancreatic cancer	0.00048	0.00048	CcSEcCtD
Varenicline—Sinusitis—Doxorubicin—pancreatic cancer	0.000479	0.000479	CcSEcCtD
Varenicline—Dizziness—Fluorouracil—pancreatic cancer	0.000478	0.000478	CcSEcCtD
Varenicline—Visual impairment—Epirubicin—pancreatic cancer	0.000478	0.000478	CcSEcCtD
Varenicline—Rash—Irinotecan—pancreatic cancer	0.000476	0.000476	CcSEcCtD
Varenicline—Dermatitis—Irinotecan—pancreatic cancer	0.000476	0.000476	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000476	0.000476	CcSEcCtD
Varenicline—Headache—Irinotecan—pancreatic cancer	0.000473	0.000473	CcSEcCtD
Varenicline—Insomnia—Docetaxel—pancreatic cancer	0.000472	0.000472	CcSEcCtD
Varenicline—Erythema multiforme—Epirubicin—pancreatic cancer	0.000469	0.000469	CcSEcCtD
Varenicline—Vomiting—Gemcitabine—pancreatic cancer	0.000468	0.000468	CcSEcCtD
Varenicline—Bradycardia—Doxorubicin—pancreatic cancer	0.000467	0.000467	CcSEcCtD
Varenicline—Dyspnoea—Docetaxel—pancreatic cancer	0.000466	0.000466	CcSEcCtD
Varenicline—Somnolence—Docetaxel—pancreatic cancer	0.000464	0.000464	CcSEcCtD
Varenicline—Rash—Gemcitabine—pancreatic cancer	0.000464	0.000464	CcSEcCtD
Varenicline—Dermatitis—Gemcitabine—pancreatic cancer	0.000464	0.000464	CcSEcCtD
Varenicline—Eye disorder—Epirubicin—pancreatic cancer	0.000463	0.000463	CcSEcCtD
Varenicline—Tinnitus—Epirubicin—pancreatic cancer	0.000462	0.000462	CcSEcCtD
Varenicline—Headache—Gemcitabine—pancreatic cancer	0.000461	0.000461	CcSEcCtD
Varenicline—Cardiac disorder—Epirubicin—pancreatic cancer	0.00046	0.00046	CcSEcCtD
Varenicline—Vomiting—Fluorouracil—pancreatic cancer	0.00046	0.00046	CcSEcCtD
Varenicline—Dyspepsia—Docetaxel—pancreatic cancer	0.00046	0.00046	CcSEcCtD
Varenicline—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000456	0.000456	CcSEcCtD
Varenicline—Rash—Fluorouracil—pancreatic cancer	0.000456	0.000456	CcSEcCtD
Varenicline—Dermatitis—Fluorouracil—pancreatic cancer	0.000456	0.000456	CcSEcCtD
Varenicline—Decreased appetite—Docetaxel—pancreatic cancer	0.000454	0.000454	CcSEcCtD
Varenicline—Headache—Fluorouracil—pancreatic cancer	0.000453	0.000453	CcSEcCtD
Varenicline—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000453	0.000453	CcSEcCtD
Varenicline—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000452	0.000452	CcSEcCtD
Varenicline—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000451	0.000451	CcSEcCtD
Varenicline—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000451	0.000451	CcSEcCtD
Varenicline—Fatigue—Docetaxel—pancreatic cancer	0.00045	0.00045	CcSEcCtD
Varenicline—Angiopathy—Epirubicin—pancreatic cancer	0.00045	0.00045	CcSEcCtD
Varenicline—Urethral disorder—Doxorubicin—pancreatic cancer	0.00045	0.00045	CcSEcCtD
Varenicline—Nausea—Irinotecan—pancreatic cancer	0.000449	0.000449	CcSEcCtD
Varenicline—Immune system disorder—Epirubicin—pancreatic cancer	0.000448	0.000448	CcSEcCtD
Varenicline—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000447	0.000447	CcSEcCtD
Varenicline—Pain—Docetaxel—pancreatic cancer	0.000447	0.000447	CcSEcCtD
Varenicline—Constipation—Docetaxel—pancreatic cancer	0.000447	0.000447	CcSEcCtD
Varenicline—Chills—Epirubicin—pancreatic cancer	0.000445	0.000445	CcSEcCtD
Varenicline—Arrhythmia—Epirubicin—pancreatic cancer	0.000443	0.000443	CcSEcCtD
Varenicline—Visual impairment—Doxorubicin—pancreatic cancer	0.000442	0.000442	CcSEcCtD
Varenicline—Nausea—Gemcitabine—pancreatic cancer	0.000437	0.000437	CcSEcCtD
Varenicline—Mental disorder—Epirubicin—pancreatic cancer	0.000434	0.000434	CcSEcCtD
Varenicline—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000434	0.000434	CcSEcCtD
Varenicline—Malnutrition—Epirubicin—pancreatic cancer	0.000432	0.000432	CcSEcCtD
Varenicline—Erythema—Epirubicin—pancreatic cancer	0.000432	0.000432	CcSEcCtD
Varenicline—Feeling abnormal—Docetaxel—pancreatic cancer	0.00043	0.00043	CcSEcCtD
Varenicline—Nausea—Fluorouracil—pancreatic cancer	0.00043	0.00043	CcSEcCtD
Varenicline—Eye disorder—Doxorubicin—pancreatic cancer	0.000429	0.000429	CcSEcCtD
Varenicline—Tinnitus—Doxorubicin—pancreatic cancer	0.000428	0.000428	CcSEcCtD
Varenicline—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000427	0.000427	CcSEcCtD
Varenicline—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000426	0.000426	CcSEcCtD
Varenicline—Flatulence—Epirubicin—pancreatic cancer	0.000425	0.000425	CcSEcCtD
Varenicline—Dysgeusia—Epirubicin—pancreatic cancer	0.000423	0.000423	CcSEcCtD
Varenicline—Back pain—Epirubicin—pancreatic cancer	0.000417	0.000417	CcSEcCtD
Varenicline—Angiopathy—Doxorubicin—pancreatic cancer	0.000416	0.000416	CcSEcCtD
Varenicline—Muscle spasms—Epirubicin—pancreatic cancer	0.000415	0.000415	CcSEcCtD
Varenicline—Immune system disorder—Doxorubicin—pancreatic cancer	0.000414	0.000414	CcSEcCtD
Varenicline—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000413	0.000413	CcSEcCtD
Varenicline—Abdominal pain—Docetaxel—pancreatic cancer	0.000413	0.000413	CcSEcCtD
Varenicline—Body temperature increased—Docetaxel—pancreatic cancer	0.000413	0.000413	CcSEcCtD
Varenicline—Chills—Doxorubicin—pancreatic cancer	0.000412	0.000412	CcSEcCtD
Varenicline—Arrhythmia—Doxorubicin—pancreatic cancer	0.00041	0.00041	CcSEcCtD
Varenicline—Vision blurred—Epirubicin—pancreatic cancer	0.000407	0.000407	CcSEcCtD
Varenicline—Mental disorder—Doxorubicin—pancreatic cancer	0.000402	0.000402	CcSEcCtD
Varenicline—Ill-defined disorder—Epirubicin—pancreatic cancer	0.0004	0.0004	CcSEcCtD
Varenicline—Erythema—Doxorubicin—pancreatic cancer	0.000399	0.000399	CcSEcCtD
Varenicline—Malnutrition—Doxorubicin—pancreatic cancer	0.000399	0.000399	CcSEcCtD
Varenicline—Anaemia—Epirubicin—pancreatic cancer	0.000399	0.000399	CcSEcCtD
Varenicline—Agitation—Epirubicin—pancreatic cancer	0.000397	0.000397	CcSEcCtD
Varenicline—Flatulence—Doxorubicin—pancreatic cancer	0.000394	0.000394	CcSEcCtD
Varenicline—Dysgeusia—Doxorubicin—pancreatic cancer	0.000391	0.000391	CcSEcCtD
Varenicline—Malaise—Epirubicin—pancreatic cancer	0.000389	0.000389	CcSEcCtD
Varenicline—Vertigo—Epirubicin—pancreatic cancer	0.000388	0.000388	CcSEcCtD
Varenicline—Syncope—Epirubicin—pancreatic cancer	0.000387	0.000387	CcSEcCtD
Varenicline—Back pain—Doxorubicin—pancreatic cancer	0.000386	0.000386	CcSEcCtD
Varenicline—Hypersensitivity—Docetaxel—pancreatic cancer	0.000385	0.000385	CcSEcCtD
Varenicline—Muscle spasms—Doxorubicin—pancreatic cancer	0.000384	0.000384	CcSEcCtD
Varenicline—Palpitations—Epirubicin—pancreatic cancer	0.000381	0.000381	CcSEcCtD
Varenicline—Loss of consciousness—Epirubicin—pancreatic cancer	0.000379	0.000379	CcSEcCtD
Varenicline—Cough—Epirubicin—pancreatic cancer	0.000377	0.000377	CcSEcCtD
Varenicline—Vision blurred—Doxorubicin—pancreatic cancer	0.000376	0.000376	CcSEcCtD
Varenicline—Asthenia—Docetaxel—pancreatic cancer	0.000375	0.000375	CcSEcCtD
Varenicline—Convulsion—Epirubicin—pancreatic cancer	0.000374	0.000374	CcSEcCtD
Varenicline—Hypertension—Epirubicin—pancreatic cancer	0.000373	0.000373	CcSEcCtD
Varenicline—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000371	0.000371	CcSEcCtD
Varenicline—Pruritus—Docetaxel—pancreatic cancer	0.000369	0.000369	CcSEcCtD
Varenicline—Anaemia—Doxorubicin—pancreatic cancer	0.000369	0.000369	CcSEcCtD
Varenicline—Chest pain—Epirubicin—pancreatic cancer	0.000367	0.000367	CcSEcCtD
Varenicline—Myalgia—Epirubicin—pancreatic cancer	0.000367	0.000367	CcSEcCtD
Varenicline—Arthralgia—Epirubicin—pancreatic cancer	0.000367	0.000367	CcSEcCtD
Varenicline—Agitation—Doxorubicin—pancreatic cancer	0.000367	0.000367	CcSEcCtD
Varenicline—Anxiety—Epirubicin—pancreatic cancer	0.000366	0.000366	CcSEcCtD
Varenicline—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000365	0.000365	CcSEcCtD
Varenicline—Discomfort—Epirubicin—pancreatic cancer	0.000363	0.000363	CcSEcCtD
Varenicline—Malaise—Doxorubicin—pancreatic cancer	0.00036	0.00036	CcSEcCtD
Varenicline—Dry mouth—Epirubicin—pancreatic cancer	0.000359	0.000359	CcSEcCtD
Varenicline—Vertigo—Doxorubicin—pancreatic cancer	0.000359	0.000359	CcSEcCtD
Varenicline—Syncope—Doxorubicin—pancreatic cancer	0.000358	0.000358	CcSEcCtD
Varenicline—Diarrhoea—Docetaxel—pancreatic cancer	0.000357	0.000357	CcSEcCtD
Varenicline—Palpitations—Doxorubicin—pancreatic cancer	0.000353	0.000353	CcSEcCtD
Varenicline—Oedema—Epirubicin—pancreatic cancer	0.000352	0.000352	CcSEcCtD
Varenicline—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000351	0.000351	CcSEcCtD
Varenicline—Infection—Epirubicin—pancreatic cancer	0.00035	0.00035	CcSEcCtD
Varenicline—Cough—Doxorubicin—pancreatic cancer	0.000348	0.000348	CcSEcCtD
Varenicline—Shock—Epirubicin—pancreatic cancer	0.000347	0.000347	CcSEcCtD
Varenicline—Convulsion—Doxorubicin—pancreatic cancer	0.000346	0.000346	CcSEcCtD
Varenicline—Nervous system disorder—Epirubicin—pancreatic cancer	0.000345	0.000345	CcSEcCtD
Varenicline—Dizziness—Docetaxel—pancreatic cancer	0.000345	0.000345	CcSEcCtD
Varenicline—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000345	0.000345	CcSEcCtD
Varenicline—Hypertension—Doxorubicin—pancreatic cancer	0.000345	0.000345	CcSEcCtD
Varenicline—Tachycardia—Epirubicin—pancreatic cancer	0.000344	0.000344	CcSEcCtD
Varenicline—Skin disorder—Epirubicin—pancreatic cancer	0.000342	0.000342	CcSEcCtD
Varenicline—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000341	0.000341	CcSEcCtD
Varenicline—Chest pain—Doxorubicin—pancreatic cancer	0.00034	0.00034	CcSEcCtD
Varenicline—Myalgia—Doxorubicin—pancreatic cancer	0.00034	0.00034	CcSEcCtD
Varenicline—Arthralgia—Doxorubicin—pancreatic cancer	0.00034	0.00034	CcSEcCtD
Varenicline—Anxiety—Doxorubicin—pancreatic cancer	0.000339	0.000339	CcSEcCtD
Varenicline—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000338	0.000338	CcSEcCtD
Varenicline—Discomfort—Doxorubicin—pancreatic cancer	0.000336	0.000336	CcSEcCtD
Varenicline—Anorexia—Epirubicin—pancreatic cancer	0.000336	0.000336	CcSEcCtD
Varenicline—Dry mouth—Doxorubicin—pancreatic cancer	0.000333	0.000333	CcSEcCtD
Varenicline—Vomiting—Docetaxel—pancreatic cancer	0.000332	0.000332	CcSEcCtD
Varenicline—Rash—Docetaxel—pancreatic cancer	0.000329	0.000329	CcSEcCtD
Varenicline—Hypotension—Epirubicin—pancreatic cancer	0.000329	0.000329	CcSEcCtD
Varenicline—Dermatitis—Docetaxel—pancreatic cancer	0.000329	0.000329	CcSEcCtD
Varenicline—Headache—Docetaxel—pancreatic cancer	0.000327	0.000327	CcSEcCtD
Varenicline—Oedema—Doxorubicin—pancreatic cancer	0.000326	0.000326	CcSEcCtD
Varenicline—Infection—Doxorubicin—pancreatic cancer	0.000324	0.000324	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000321	0.000321	CcSEcCtD
Varenicline—Shock—Doxorubicin—pancreatic cancer	0.000321	0.000321	CcSEcCtD
Varenicline—Nervous system disorder—Doxorubicin—pancreatic cancer	0.00032	0.00032	CcSEcCtD
Varenicline—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000319	0.000319	CcSEcCtD
Varenicline—Insomnia—Epirubicin—pancreatic cancer	0.000319	0.000319	CcSEcCtD
Varenicline—Tachycardia—Doxorubicin—pancreatic cancer	0.000318	0.000318	CcSEcCtD
Varenicline—Skin disorder—Doxorubicin—pancreatic cancer	0.000317	0.000317	CcSEcCtD
Varenicline—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000315	0.000315	CcSEcCtD
Varenicline—Dyspnoea—Epirubicin—pancreatic cancer	0.000314	0.000314	CcSEcCtD
Varenicline—Somnolence—Epirubicin—pancreatic cancer	0.000313	0.000313	CcSEcCtD
Varenicline—Anorexia—Doxorubicin—pancreatic cancer	0.000311	0.000311	CcSEcCtD
Varenicline—Nausea—Docetaxel—pancreatic cancer	0.00031	0.00031	CcSEcCtD
Varenicline—Dyspepsia—Epirubicin—pancreatic cancer	0.00031	0.00031	CcSEcCtD
Varenicline—Decreased appetite—Epirubicin—pancreatic cancer	0.000306	0.000306	CcSEcCtD
Varenicline—Hypotension—Doxorubicin—pancreatic cancer	0.000305	0.000305	CcSEcCtD
Varenicline—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000304	0.000304	CcSEcCtD
Varenicline—Fatigue—Epirubicin—pancreatic cancer	0.000304	0.000304	CcSEcCtD
Varenicline—Pain—Epirubicin—pancreatic cancer	0.000301	0.000301	CcSEcCtD
Varenicline—Constipation—Epirubicin—pancreatic cancer	0.000301	0.000301	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000297	0.000297	CcSEcCtD
Varenicline—Insomnia—Doxorubicin—pancreatic cancer	0.000295	0.000295	CcSEcCtD
Varenicline—Dyspnoea—Doxorubicin—pancreatic cancer	0.000291	0.000291	CcSEcCtD
Varenicline—Feeling abnormal—Epirubicin—pancreatic cancer	0.00029	0.00029	CcSEcCtD
Varenicline—Somnolence—Doxorubicin—pancreatic cancer	0.00029	0.00029	CcSEcCtD
Varenicline—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000288	0.000288	CcSEcCtD
Varenicline—Dyspepsia—Doxorubicin—pancreatic cancer	0.000287	0.000287	CcSEcCtD
Varenicline—Decreased appetite—Doxorubicin—pancreatic cancer	0.000283	0.000283	CcSEcCtD
Varenicline—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000281	0.000281	CcSEcCtD
Varenicline—Fatigue—Doxorubicin—pancreatic cancer	0.000281	0.000281	CcSEcCtD
Varenicline—Urticaria—Epirubicin—pancreatic cancer	0.00028	0.00028	CcSEcCtD
Varenicline—Pain—Doxorubicin—pancreatic cancer	0.000279	0.000279	CcSEcCtD
Varenicline—Constipation—Doxorubicin—pancreatic cancer	0.000279	0.000279	CcSEcCtD
Varenicline—Abdominal pain—Epirubicin—pancreatic cancer	0.000278	0.000278	CcSEcCtD
Varenicline—Body temperature increased—Epirubicin—pancreatic cancer	0.000278	0.000278	CcSEcCtD
Varenicline—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000269	0.000269	CcSEcCtD
Varenicline—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000267	0.000267	CcSEcCtD
Varenicline—Hypersensitivity—Epirubicin—pancreatic cancer	0.00026	0.00026	CcSEcCtD
Varenicline—Urticaria—Doxorubicin—pancreatic cancer	0.000259	0.000259	CcSEcCtD
Varenicline—Body temperature increased—Doxorubicin—pancreatic cancer	0.000258	0.000258	CcSEcCtD
Varenicline—Abdominal pain—Doxorubicin—pancreatic cancer	0.000258	0.000258	CcSEcCtD
Varenicline—Asthenia—Epirubicin—pancreatic cancer	0.000253	0.000253	CcSEcCtD
Varenicline—Pruritus—Epirubicin—pancreatic cancer	0.000249	0.000249	CcSEcCtD
Varenicline—Diarrhoea—Epirubicin—pancreatic cancer	0.000241	0.000241	CcSEcCtD
Varenicline—Hypersensitivity—Doxorubicin—pancreatic cancer	0.00024	0.00024	CcSEcCtD
Varenicline—Asthenia—Doxorubicin—pancreatic cancer	0.000234	0.000234	CcSEcCtD
Varenicline—Dizziness—Epirubicin—pancreatic cancer	0.000233	0.000233	CcSEcCtD
Varenicline—Pruritus—Doxorubicin—pancreatic cancer	0.000231	0.000231	CcSEcCtD
Varenicline—Vomiting—Epirubicin—pancreatic cancer	0.000224	0.000224	CcSEcCtD
Varenicline—Diarrhoea—Doxorubicin—pancreatic cancer	0.000223	0.000223	CcSEcCtD
Varenicline—Rash—Epirubicin—pancreatic cancer	0.000222	0.000222	CcSEcCtD
Varenicline—Dermatitis—Epirubicin—pancreatic cancer	0.000222	0.000222	CcSEcCtD
Varenicline—Headache—Epirubicin—pancreatic cancer	0.000221	0.000221	CcSEcCtD
Varenicline—Dizziness—Doxorubicin—pancreatic cancer	0.000216	0.000216	CcSEcCtD
Varenicline—Nausea—Epirubicin—pancreatic cancer	0.000209	0.000209	CcSEcCtD
Varenicline—Vomiting—Doxorubicin—pancreatic cancer	0.000207	0.000207	CcSEcCtD
Varenicline—Rash—Doxorubicin—pancreatic cancer	0.000206	0.000206	CcSEcCtD
Varenicline—Dermatitis—Doxorubicin—pancreatic cancer	0.000205	0.000205	CcSEcCtD
Varenicline—Headache—Doxorubicin—pancreatic cancer	0.000204	0.000204	CcSEcCtD
Varenicline—Nausea—Doxorubicin—pancreatic cancer	0.000194	0.000194	CcSEcCtD
